Ojectives: The proto-oncogenes c-fos, c-myc and H-ras have been shown to rise in a characteristic pattern in the left ventricle undergoing hypertrophy in the coarctation model of experimental hypertension and there is some evidence to suggest that they might play a role in the initiation of hypertrophic growth. However, in vivo studies do not discriminate between the direct effects of pressure and pressure-independent trophic stimuli such as angiotensin II. To examine these influences separately we studied isolated working hearts exposed to different afterloads in the presence or absence of angiotensin II. Methods: Hearts from normotensive female Wistar rats were perfused with a modified Krebs-Henseleit solution, with and without angiotensin II (100 nmol/l) and exposed to low (60 mmHg) or high (140 mmHg) afterload (n > 17/group). Proto-oncogene mRNA induction in the left ventricle was assessed by Northern blot analysis. Results: Aortic pressures were 101 + 14/63 f 6 mmHg (mean f s.d.) with low and 175 f 13/93 rf: 20 mmHg with high afterload; hearts in both groups maintained a stable cardiac output over 240 min, except for high afterload hearts not perfused with angiotensin II, which showed a 59% drop by the end of the experiment (P < 0.001). There was a 50% (32%. 72%) (geometric mean and 95% confidence interval) increase of c-myc and 54% (27%, 86%) increase in c-fos, but a 32% (258, 40%) suppression of H-ras with high (140 mmHg) as compared with low (60 mmHg) afterloads (P < 0.0001 for each). There was no significant difference in c-myc and c-fis induction with different levels of high afterload (110, 120, 140 mmHg), but for H-ras suppression progressively increased with increasing afterload (P -0.003). At high afterload, levels of c-fis rose at 30 min and peaked at 60 min. c-myc continued to rise up to 240 min, and H-rur was suppressed at all four time points. The addition of angiotensin II (100 nmol/l) to the perfusate resulted in 18% (68, 28%; P -0.006) lower c-myc levels, 12% ( -6%, 28%; P = 0.18) lower c-fos levels and an 11% (-0.196, 24%; P -0.056) increase of H-ras. ConelusIon: The isolated perfused working rat heart is capable of performing stably for a period of at least 240 min at high afterload pressures comparable to those encountered in hypertension. A proto-oncogene induction similar to that seen in the hypertrophying heart can be induced by increased pressure alone, without the mediating effects of circulating angiotensin II. Hearts perfused with angiotensin II showed a more stable performance at high levels of afterload which was associated with a minor attenuation of pressure-induced changes in proto-oncogene expression.
Introduction
The precise stimuli that induce left ventricular hypertrophy are not known, but the degree of hypertension [1, 2] and peripheral resistance [3] have been identified as major determinants in man. Mechanical factors such as cardiac load, systolic wall stress and myocyte stretch have been shown to be involved in the regulation of growth of the heart in vivo [4-61 and cellular changes suggestive of hypertrophy in vitro [7-lo] . However, evidence from stud-* Correspondiig author. Tel. (+44-161) 787-5578; Fax (+44-161) .
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ies of human hypertension [ 11,121 and animal models [ 13,141 suggests that reversal of haemodynamic overload by antihypertensive treatment does not invariably prevent or reverse the development of left ventricular hypertrophy. It is therefore likely that, in addition to mechanical stimuli, other factors, such as neuroendocrine activation, play an important role, Angiotensin II has been shown to have pressure-independent trophic effects on myocytes in culture [15, 16] and in the intact animal [13] . The exact relation between angiotensin II and cardiac load in the development of hypertrophy is not known, but there is evidence to suggest that angiotensin II might mediate or potentiate load-induced growth signals [ 17,181. Cardiac myocytes can divide only in the foetal and neonatal periods and afterwards the heart responds to most stimuli by an increase in the mass and volume of each individual myocyte (hypertrophy) [ 191. Proto-oncogenes were first identified in malignant tumours, but have since been recognized as normal cellular genes involved in the regulation of growth, development, differentiation and cellular adaptation to stress [20-221. The development of ventricular hypertrophy has been found to be associated with induction of a number of proto-oncogenes in several experimental models of hypertension [4-61. The protooncogenes c-j& and c-myc encode nuclear proteins that show a complex pattern of distribution and expression suggesting a correlation with cellular differentiation and proliferation. In non-neoplastic cells c-myc expression is dependent on. mitogenic stimuli, and is required for cell proliferation and to prevent differentiation. The Myc protein has the structure of a transcription factor and forms heterodimers with Max, a protein which is expressed constitutively. Transcriptional promoters containing the CAC(G/A)TG sequence are found on several genes and can be regulated by Myc/Max. While it is assumed that targets for Myc/Max function include genes controlling cell division and death, most targets still remain to be identified 123,241. In the heart c-myc is expressed throughout the foetal period [25] and, transiently, after the induction of coarctation of the aorta [4] . Fos, the protein encoded by c-fos, forms heterodimers with c-jun and affects transcription by binding to a short DNA sequence (TGACTCA) referred to as the TRE (12-tetradecanoylphorbol-l3-acetate) response element. Its role in cell proliferation is established in 3T3 cells where antisense RNA inhibits this process [21] . c-fos is detectable in unstressed adult myocytes but also rises transiently after the induction of coarctation of the aorta [4] . In cultured myocytes c-fos transcription can be increased by cell stretch and protein kinase C activation [9, 10] , and also by humoral stimuli such as phenylephrine, isoproterenol [26] and angiotensin II [27] . H-ras encodes a 21 kDa protein that is involved in the transduction of growth and differentiation signals initiated by receptor and non-receptor tyrosine kinases [28, 29] . It is associated with several known signalling pathways including those of RAF-I, PKC, MEK and MAP kinase [30,3l] . In isolated myocytes injection of activated Ras induc,es expression of both the c-fos and atrial natriuretic factor genes. The hypertrophic effect of alpha-adrenergic agonists on stimulation of the ANF promoter is inhibited by a dominant interfering Ras mutant 1321.
Experimental coarctation of the aorta rapidly produces left ventricular hypertrophy in the rat and this is associated with increased levels of c-myc, c-fos and H-rus mRNA [4-6,33-351. However, this model of hypertension is associated with high concentrations of circulating angiotensin II. In vivo it is not possible to completely dissociate pressure-induced stimulation of these genes from the contributions of hormones which may be trophic in their own right. To examine these factors separately we measured levels of c-myc, c-fos and H-ras mRNA in isolated working rat hearts exposed to high and low afterload pressures perfused with a plain buffer or buffer containing angiotensin II. In this way it was possible to address the issue of whether pressure overload or angiotensin II induce these genes alone or in synergy.
Methods

Experimental animals and working heart preparations
Female Wistar rats (200-300 g) were obtained from Charles River Breeding Laboratories, UK and fed ad libiturn on normal rat chow (B&K Universal, Hull, UK) and tap water. The investigation was performed in accordance with the Home Office Guidance on the Operation of the Animals (Scientific Procedures) Act 1986, published by Her Majesty's Stationary Office, London. One week before experimentation the mean arterial pressure was confirmed as normal ( < 120 mmHg, mean 110 f 1.25 mmHg) by tail cuff plethysmography under light ether anaesthesia in a randomly selected 20% of the total population. Gn the day of the study rats were anaesthetized with an intraperitoneal injection of pentobarbitone (Zeneca, Alderley Edge, UK, 140 mmol/kg) 15 min before sacrifice. Sodium heparin (200 III) was injected through the femoral vein and allowed to circulate for 30 s. After thoracotomy the heart, major vessels and pulmonary hila were excised with one cut and arrested by immersion in ice-cold normal saline. The aorta was identified, tied onto the aortic cannula and perfused retrogradely [36] with a pressure of 60 mmHg. The pulmonary vessels were tied en bloc at the hilum and an incision was made in the proximal pulmonary artery to allow collection of coronary flow and decompress the right ventricle. The left atrium was cammlated and working mode with antegrade perfusion started after about 10 min of stabilization on retrograde perfusion [37] . Preload was set at 10 mmHg. Initial afterload was 60 mmHg for all hearts. After a period of 10 min of stabilization in working heart mode, the afterload was gradually increased to 110, 120 or 140 mmHg (which was the highest level that could be maintained with stable function) over a 5-10 min period in the high afterload group. In the low afterload group afterload was kept unchanged at 60 mmHg. The perfusate was a modified Krebs-Henseleit buffer containing (mmol/l): sodium chloride 116, sodium bicarbonate 25, sodium dihydrogen phosphate 0.4, potassium chloride 5.2, calcium chloride 2.5, magnesium chloride 1.1, dextrose 5.5, sodium pyruvate 2.0 equilibrated with 95% 0,/5% CO, at 37°C. The perfusate was not recirculated. In some of the hearts 100 nmol/l angiotensin II was added to the equilibrated buffer at the end of the 10 min stabilization period. The perfusate reservoir was replenished regularly with fresh perfusate containing angiotensin II. Aortic pressure, heart rate, aortic and coronary flow were measured at 15 min intervals. Hearts were considered functionally stable if the heart rate was regular and above 200 beats per minute, a measurable cardiac output was maintained and systolic pressure did not fall. Hearts that did not fit these criteria were deemed to be failures and were not included in the analysis.
At the end of each experiment the heart was weighed, the left ventricle dissected, snap frozen in liquid nitrogen and stored at -70°C.
mRNA determinations
Total cellular RNA was isolated using the acid guanidinium thiocyanate-phenol-chloroform method described by Chomczynski and Sacchi [38] and quantified by spectrophotometry. Northern blots were prepared by standard techniques [39] . In brief 20 pg (for c-for and H-ias) or 40 pg (for c-myc) of total RNA were fractionated by gel electrophoresis in 1% agarose gels containing 6% formaldehyde. Gels were blotted overnight onto Hybond N (Amersham International, UK) with 10 X SSPE (1 X SSPE 150 mmol/l sodium chloride, 10 mmol/l sodium dihydrogen phosphate and 1 mMo1 EDTA at pH 7.4) and air-dried. RNA was fixed to the membrane by UV radiation for 60 s and the positions of the 28s and 18s ribosomal bands were marked.
cDNA probes were labelled to a high specific activity with a-32P-dCTP (Amersham International, UK) by random hexamer primer labelling [4O]. The following cDNAs were used: c-myc (murine, 0.9 kb Xbal/Sstl fragment of the pSVc myc plasmid covering exon 2 [41] ), c-fos (1.2 kb HincII/EcoRI fragment isolated from BALB/c mouse DNA [42] ), both were donated by G. Cowling, Paterson Institute, Manchester. H-r-as (576 bp PCR fragment covering exon 4 isolated from the BALB murine sarcoma virus) was donated by K. Brown, Beardson Institute, Glasgow [43] and GAPDH (rodent, 700 bp PCR fragment running from bp 300 to 920) was donated by R. Fulton. Chester Beatty Laboratories, Glasgow [44] . PCR was performed according to standard protocols [45] for 35 cycles using a thermal cycler (Perkm-Elmer, Birch Wood Science Park, Wanington), 20 bp forward and backward primers (Oligonucleotide Service, University of Leicester) and Taq polymerase (Ampli Taq, Perkin-Elmer). cDNA probes were purified by gel electrophoresis and extracted using the Geneclean kit (Bio 101 Inc., USA).
2.2.1.1. Hybridization. Blots were prehybridized for 240 min at 68°C in 1% bovine serum albumin, 7% sodium dodecyl sulphate (SDS) and 0.25 mol/l high salt buffer (58.4 g sodium chloride, 71 g disodium hydrogen phosphate, 4 ml 85% phosphoric acid made up to a volume of 500 ml with water) [46] . Hybridization was performed overnight at 68°C in the above buffer with minor modifications (0.5% bovine serum albumin, 7% SDS and 0.25 mol/l high salt buffer, 10% dextran sulphate). Filters were washed once for 15 min at 68°C in 2 X SSPE with 1% SDS and then in 0.2 X SSPE with 0.1% SDS before exposing to X-Ray film (Kodak) at -70°C for 180 min (GAPDH) to 4 weeks (c-myc). All filters were stripped according to the manufacturer's instructions and reprobed with GAPDH as an internal control.
2.2.1.2. Quantitation. Autoradiographs were analysed by scanning laser densitometry using the Gelscan XL programme (Pharmacia, LKB Biotechnology, Uppsala, Sweden) and the data were expressed in densitometric units. Results for c-myc, c-fos and H-ras were corrected for loading by division by GAPDH values from the same slot (Fig. 3 ). Any two filters had at least 4 samples in common. These were used for the calculation of conversion factors for inter-filter comparisons. 
Statistics
A total of 145 hearts, divided into different experimental groups, was included in the analysis. The proto-oncogene data were transformed to achieve normality and constant variance by log transformation after adding 1 to allow for zero values. The main procedure used was three-way analysis of variance (ANOVA) with time (30, 60, 120 and 240 min), pressure (60 and 140 mmHg) and angiotensin II (0 and 100 mmol/l) as factors. All interaction terms were originally fitted and then removed individ-ually. None of the interaction terms was significant individually and therefore only the F value for removing all interactions simultaneously is given in the results. The main effects of time, pressure and angiotensin II were left in the model even if non-significant and the coefficients for pressure and angiotensin II were backtransformed to give a percentage effect. Means and confidence intervals were calculated on the transformed scale and backtransformed for presentation.
The effect of different levels of afterload (60, 110, 120, 140 mmHg) at 1 h in buffer-perfused hearts was analyzed using one-way ANOVA. Comparisons were made between low (60 mmHg) and high afterload (110, 120 and 140 mmHg) and between the different levels of high afterload (110, 120 and 140 mmHg).
The haemodynamic parameters showed considerable heterogeneity of variance across the four groups (afterload = 60 and 140 mmHg and angiotensin II = 0 and 100 nmol/l), so unpaired t-tests were applied with Welch's modification for unequal variances. Variances were compared with Levene's test. Comparisons were made of 0 and 100 nmol/l angiotensin II within each afterload group and 60 and 140 mmHg afterload within each angiotensin II group. A significance level of 1% was used to allow for the multiple comparisons of haemodynamic parameters. Elsewhere a significance level of 5% was used.
Results
Cardiac pegonnance
Aortic pressure, heart rate, coronary flow and cardiac output are illustrated in Table 1 . In buffer-perfused hearts exposed to low afterload, aortic pressure was 101 f 14/63 f 6 rmnHg (mean f s.d.), heart rate 251 f 31 beats/mm, pulmonary flow 22 f 20 and cardiac output 39 f 15 ml/min. There was no significant change within the performance of each heart over time in 30, 60, 120 and 240 min experiments. In hearts run at high afterload aortic pressure was significantly higher (175 f 13/93 f 20 mmHg, P < 0.001) and cardiac output lower (19 f 12 ml/min, P < 0.001). There was also a 2% decline in systolic pressures and 59% fall in cardiac output from the start to the end of the experiment. In angiotensin II-perfused hearts the systolic-diastolic pressure difference was smaller than in buffer-perfused hearts in both low (40% less in the angiotensin II-treated group, P < 0.001) and high afterload hearts (20% less in the angiotensin II-treated group, P = 0.03). This narrowing of the systolic-diastolic difference was observable at the start and at the end of the experiment. The drop of cardiac output from the start to the end of the experiment observed at high afterload pressure was not observed in angiotensin II treated hearts (P < 0.001). Pulmonary flow was reduced by angiotensin II both in low ( -32%, P = 0.13) and high afterload hearts (-498, P < 0.001). The heart rate was not significantly affected by afterload or angiotensin II.
Stability of angiotensin II
The addition of angiotensin II (100 mnol/l) to the perfusate was associated with a typical haemodynamic response comprising transient narrowing of the pulse pressure [47] (Fig. 1 ) and reduction in cardiac output. In order to ensure that there was no degradation of angiotensin II in the perfusate its biological activity was checked at various time points by adding aliquots of used perfusate obtained from coronary effluent and aortic flow or unused fresh perfusate to a rat skin resistance artery mounted as a ring Blood pressure (BP), heart rate and cardiac output (CO) in isolated perfused working heart subjected to 60 or 140 mmHg at&load. Results are given as meanf 1 s.d. Differences between high and low afterload groups were significant for all lmeasured parameters (P < 0.001) except heart rate and coronary flow, and were not indicated in the table to simplify the presentation. Differences between angiotensin II (AR) and no angiotensin II (no AR) were given separately for low and high afterload groups. preparation on an isometric wire myograph [48] . A characteristic contractile response was elicited when the perfusate contained angiotensin II (Fig. 2) but not with buffer alone and was equivalent to that seen when freshly reconstituted AR was added to the organ bath.
3.3. The efict of the experimental set-up on proto-oncogene expression
In order to assess the effects of premeditation and the baseline experimental conditions on proto-oncogene expression, hearts taken directly ex vivo with and without premeditation were compared with hearts working against an afterload of 60 mmHg. While it is impossible to exactly recreate the in vivo workload at normal pressures in the isolated buffer-perfused heart, we have chosen this afterload as the baseline since it is the optimal setting for stable cardiac function 136,491. In freshly excised left ventricles Potaaaium KrebsAnobtenainP. -Hemeleit cafuaete i mini Fig. 2 . Biological activity of angiotensin II in tbe perfitsate. A 10 ml sample of perfusate containing 100 mnol/l angiotensin II and oxygenated for 1 h at 37°C was superfused over a rat skin resistance vessel in a myograph. A characteristic short-lived contraction (tachyphylaxis) was observed. As comparison, the maximal (potassium~induced) contraction in the same vessel is shown to the left. Fig. 3 . Effect of afterload and angiotensin II on induction of c-myc, c-fos and H-ras mRNAs. Isolated pertimed working hearts wete exposed to 60 or 140 mmHg afterload for 1 h in the presence or absence of angiotensin II 100 nmol/l in the perfusate. Results from a heart taken directly ex vivo and snap frozen without any further interventions are given as comparison for in vivo levels. Total RNA (40 pg for c-myc, 20 kg for c-j&s and H-ras) was analyzed by Northern blotting and hybridized to 32 P-labelled cDNA for the respective mRNAs. Each filter was stripped and rehybridized with GAPDH mRNA to control for inequalities in loading and transfer. Molecular weight of the mRNA was estimated by the position of the 18s and 28s ribosomal bands (omitted for clarity).
of rats (n = 9) obtained immediately after sacrifice and not subjected to artificial perfusion, treated with pentobarbitone and heparin as used for premeditation of the experimental hearts, c-myc and c-fos were not detectable. H-ras is expressed constitutively [251 (Fig. 3 ) and levels were 8.1 (7.2, 9.0) (geometric mean f ls.e.m., expressed as absolute OD units, corrected by GAPDH as described above). Results were similar for hearts freshly excised from untreated rats sacrificed by cervical dislocation (n = 8). In the buffer-perfused working heart preparation exposed to low afterload (60 mmHg) both c-myc and c-fos, but not H-ras were induced (Figs. 3 and 4) . Aftsrload (mm Hgl Fig. 4 . Effect of several different levels of afterload on proto-oncogene mRNA expression in the left ventricle. Isolated perfused working rat hearts were subjected to low (60 mmHg) and three different levels of high (110. 120 and 140 mmHg) afterload for 60 min. Total RNA (20 pg for C-$X and H-MS, 40 pg for c-myc) was analyzed by Northern blotting and hybridized to 32 P-labelled c-myc, c-for and H-ras and then GAPDH cDNA, which was used aa internal control. The resultant autoradiograph was quantified by densitometry. Numbers of hearts in each experimental group were 17 for 60 mmHg, 12 for 110 mmHg, 6 for 120 mmHg and 7 for 140 mmHg. Statistical analysis was by one-way analysis of variance.
Comparisons were made between high and low afterload with the variation partitioned into two components (60 versus 110, 120 and 140 mmHg) and also between high pressures. c-myc (top panel) was significantly induced with high afterload (P = O.OOl), but within the high afterload group there was no difference in c-myc levels. Results for c-fir (middle panel) were similar with P = 0.007 for the difference between high and low afterload. H-ras was suppressed by high afterload (P = 0.02). and within the high afterload levels were negatively related to the degree of afterload (P = 0.003).
(n > = 4) were subjected to high (140 mmHg) or low (60 mmHg) afterload with or without angiotensin II (100 nmol/l) in the perfusate for 30,60, 120 or 240 min. There for 140 mmHg/lOO nmol/l AIL Levels of c-myc, c-fir and H-ras mRNA were measured as described in Fig. 4 . The significance of differences was assessed by three-way analysis of variance with afterload, AI1 and duration of the experiment as factors. Levels of c-myc (top panel) and clfos (middle panel) were significantly increased with high atkload (P < 0.0001). H-ras levels were. suppressed by high afterload (P < 0.0001). The effects of AII were significant for c-myc (P = 0.006) and H-ras (P = 0.056) and non-significant for c-fis (P = 0.18). There were no significant interactions between time, afterload and AI1 for any of the three proto-oncogenes.
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http://cardiovascres.oxfordjournals.org/ Downloaded from levels of c-myc were 17.6%, (5.8%, 27.9%; P = 0.006) lower than in hearts perfused with buffer alone. Levels of c-fos also appeared to be lower (12.3%) C-61%, 27.5%; P = 0.181, but the difference did not achieve statistical significance. Expression of H-ras was 11.1% c-0.1%, 23.5%; P = 0.056) higher in angiotensin II-perfused hearts than in those pefused with buffer alone. The effects of angiotensin II were independent of the height of afterload and the duration of the experiments. The F values for removal of all interaction terms are reported above.
Second, H-ras is not induced, but suppressed by increased cardiac load.
4.1. The eflects of high aferload on proto-oncogene mRNA induction 3.5. The effects of different levels of afterload on protooncogene mRNA levels
In order to assess whether the observed changes in proto-oncogene levels were due to the extreme stress of very high afterload (140 mmHg) or also observable at lower levels of high afterload we examined hearts exposed for 60 min to 60, 110, 120 and 140 mmHg afterload (Fig.  4) . Levels of c-myc and c-fos were significantly higher with high (110, 120 and 140 mniHg) than with low (60 mmHg) afterload (n > 5 for each afterload group, F,,,, = 14.1 P = 0.001 for c-myc and F,,33 = 8.3 P = 0.007 for c-fos). The load-induced increase in c-myc and c-fos levels was similar for 110, 120 and 140 mmHg afterload (F2,34 = 0.3 P = 0.75 for c-myc, F2,33 = 0.8 P = 0.45 for c-fos) (Fig. 4 top and middle panels) . In contrast, H-ras levels were significantly lower at high afterload than at low afterload (F,,?. , = 6.7 P = 0.021, and this suppression became more pronounced with increasing afterload (F2,2, = 7.8 P = 0.003) (Fig. 4 bottom panel) .
Previous investigators have shown that an increase of preload from 6 to 12 mmHg, as well as increased afterload from 60 to 74 mmHg, augmented the expression of c-myc and c-fos genes in isolated buffer-perfused working hearts. Achieved aortic pressures were not reported, but are likely to lie within normal limits 171. Afterloads within the hypertensive range (140 mmHg) were first reported by James and Jones [50], but were only maintained for a short time. An increase in wall stress and force generation produced by insertion of a pressurized balloon into the left ventricle achieving ventricular pressures of 80 and 140 mmHg was maintained for 1 h and increased mRNA messages for c-fos and c-jun compared with lower pressures of 80 mmHg. No data on stability and performance of the hearts are available, and the observed effects could have been due to damage to the left ventricle [8] . We observed an increase in c-myc and c-fos mRNA in hearts subjected to a range of high and very high (1 lo-140 mmHg) afterloads and demonstrated that, even at a very high workload, aortic pressure remained stable for 4 h and cardiac output was maintained. The finding that this induction was not only observed at the very high afterload of 140 mmHg, but similarly at more moderate levels of increased afterload of 110 and 120 mmHg also confirms that the observed effect is not just a result of injury at the top range of pressures. The results also suggest that increased workload may induction of the proto-oncogenes c-myc, c-fos and H-ras not be the only factor that can trigger proto-oncogene was explored using isolated buffer-perfused hearts exposed expression in the heart. Whilst c-myc and c-fos are not to different levels of afterload in the presence or absence detectable in hearts taken out of animals and snap frozen of angiotensin II in the perfusate. For the first time it has without any further manipulation, non-working hearts perbeen possible not only passively to expose isolated perfused at normal pressures and even control hearts exposed fused rat hearts to truly high systolic pressures comparable to normal afterloads showed lower but definitely dewith those in in-vivo hypertension, but also maintain a tectable levels of expression of these genes. There is cardiac output for a period of 4 h. We are therefore able to evidence from in vivo experiments that other factors than relate the observed changes in proto-oncogene expression afterload and active force generation such as hypoxia [51] to the effects of the increase in afterload rather than to and ischaemia 1521 or infarction [53] induce c-fos and non-specific stretch or load-induced myocardial failure.
c-myc expression. Although minor degrees of hypoxia or Our results confirm the findings of earlier reports [7, 8] that ischaemia due to microemboli cannot be completely exdemonstrate that the early growth response genes c-myc cluded even in well functioning isolated buffer-perfused and C-$X can be induced in the isolated buffer-perfused hearts and may explain the detectable levels of c-myc and heart within a short period of time when exposed to an c-fos in hearts run at low afterload, these should not increased workload. Furthermore, the present study proinvalidate our results, since they apply equally to high and vides two major new findings. First, angiotensin II does low afterload groups. Indeed it has probably reduced the not induce these genes in the isolated buffer-perfused difference between the two groups since a mildly hypoxic heart, but, conversely, it appears to attenuate rather than heart may perform well at low load but would fail and boost the proto-oncogene response to increased afterload. therefore be excluded if subjected to high workload.
The efict of angiotensin II on proto-oncogene induction
Angiotensin II has been shown to be a potent stimulus for proto-oncogene induction in cultured cardiomyocytes [16, 54] and evidence for pressure-independent trophic effects has been produced for isolated perfused hearts [55] and in vivo hearts [ 131.
The lack of proto-oncogene response to angiotensin II in our experiments cannot be explained by the assumption that increased afterload alone provided a stimulus for gene induction such that the addition of a further trophic stimulus like angiotensin II could not augment this response since the addition of angiotensin II to hearts working at low afterload did not yield any different result. Nor are these results due to a physiologically abnormal level of angiotensin II. Toxic effects due to too high a concentration [56] can be excluded since our observations show that hearts treated with angiotensin II performed more stably, especially at high afterload, than those perfused with buffer alone. Equally, insufficient levels can be discounted, since 100 nmol/l angiotensin II induces a maximal physiological response in cultured cardiomyocytes [16, 55, 57] , in isolated perfused hearts [55] and in vascular smooth muscle cells [58] . Degradation of angiotensin was excluded, and the continued physiological activity in our experiments is also evidenced by the sustained reduction in the difference of systolic/diastolic pressures, a reduction of coronary flow and an improvement of cardiac output compared with non-angiotensin-treated hearts.
There are, then, three possible explanations for our findings. First, angiotensin II might have different effects in fully differentiated myocytes in the heart than in embryonal cells in culture. While angiotensin II induces the expression of a number of proto-oncogenes including c-for, c-jun, jun B and Egr-1 and second messenger pathways associated with hypertrophy in neonatal cardiomyocytes in culture, full induction of c-for requires the addition of foetal calf serum as a growth factor in adult cardiomyocytes [57] . Similarly, in isolated perfused hearts the presence of other growth factors such as those contained in serum may be necessary for angiotensin-mediated protooncogene induction. Second, it is conceivable that changes in the expression of c-myc, c-fos and H-ras are not the only mechanisms by which a hypertrophic response can be achieved. Experiments on isolated perfused hearts demonstrated an induction of protein synthesis and activation of protein kinase C, but no increase of c-for or c-jun levels with concentrations of 1 mmol/l to 1 pmol/l of angiotensin II [55] . Last, it might be argued that it is not circulating, but locally produced angiotensin II that induces hypertrophy. There is now good evidence for the presence and functional importance of a local tissue renin-angiotensin system in the heart (for a review see [59] ). Although the lack of hypertrophic response to angiotensin II might be explained by maximal induction of the tissue renin-angiotensin system by pressure alone, this is unlikely in our experiments, since angiotensin II was not ineffective, but rather reduced the proto-oncogene response to pressure-stress.
Our results, then, do not support the theory that angiotensin II plays an important role in the induction of proto-oncogenes in the very early phases of pressure-induced hypertrophy, but we cannot exclude that it induces hypertrophy by other mechanisms or, since the length of our e.xperiments did not exceed 4 h, that it might be an important factor at a later stage in the perpetuation of the hypertrophic stimulus. The latter point is strengthened by the findings of Golomb et al. who showed that continuous injection of subpressor doses of angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats [60] .
Indeed, in our study angiotensin II appeared to attenuate the afterload-related changes in proto-oncogene expression. Angiotensin II has positive inotropic effects on the heart [61, 62] , and, like sympathetic activation, it might play an important physiological role in supporting cardiac function in the early response to stressful stimuli. Our results would certainly support this hypothesis, since, as mentioned before, the performance of hearts perfused with angiotensin II was more stable at high afterload than that of hearts perfused with buffer only. The observed attenuation of afterload-induced changes in proto-oncogene levels is very small (lo-20%) and unlikely to be of physiological importance. We feel that this does not represent a direct effect on proto-oncogene induction as such, but is due to the positive inotropic actions and the improved cardiac performance.
The suppression of H-ras by high afrerload
A further notable result was the failure of induction of H-ras under conditions of high afterload which were sufficient to increase the expression of the early growth response genes c-myc and c-fos. In in-vivo models of hypertension such as coarctation of the aorta, induction of all three proto-oncogenes was observed within the first 240 min of coarctation [4] . This would support the hypothesis that increased afterload alone is not sufficient to induce H-ras and that the mediation of a humoral factor is necessary to activate H-ras gene expression.
Since there was, however, not merely a 'failure of induction' but a highly significant suppression of H-ras, the absence of stimulating humoral factors alone cannot explain our results. To our knowledge this is the first report of H-ras suppression rather than induction in response to stimulation. The apparent paradox of H-ras induction by pressure-overload in vivo and suppression in the isolated buffer-perfused working heart may be explained by the pressure-induced suppression of H-ras being masked by the effects of circulating humoral factors. Our data lend some support to this hypothesis, since angiotensin II was shown to induce H-ru.r expression and to reverse some of the pressure-induced H-ras suppression. It appears, however, unlikely that angiotensin II alone is the major humoral element responsible for the activation of H-rus gene expession since the observed induction was only weak and could also be explained by the differences in cardiac performance between buffer-perfused and angiotensin II-perfused hearts.
Clearly, these studies only extend over a relatively short period of time but expose the heart to conditions that, if sustained, would undoubtedly lead to hypertrophy in vivo. Although there is no incontrovertible evidence that a rise of the proto-oncogenes c-myc, c-fos and H-rus necessarily triggers the onset of left ventricular hypertrophy, in-vivo models of hypertension show that the development of hypertrophy is preceded by induction of these genes [6] . We cannot make any comments about the cellular localization of proto-oncogene induction, but Schunkert et al. have shown by immunocytochemistry that an increase in systolic wall stress is followed by rises in Fos protein in myocyte nuclei, with minimal staining of fibroblasts and vascular smooth muscle cells [8] . The failure of angiotensin II to augment the afterload stimulation of early growth response genes is of interest. There are obvious differences between in vivo experimental models of hypertension stimulating the renin-angiotensin system and the working heart preparation. However, in one study where pressure was raised using the induction of coarctation of the aorta between the origins of the renal arteries in the rat, there was evidence of hypertrophy in the aorta proximal to the ligature but not below, suggesting that pressure was the major stimulus rather than high circulating levels of angiotensin II [63] .
In the isolated perfused working rat heart c-myc and c-fos can be induced by increased pressure alone, without the mediating effects of circulating trophic factors. The current study would indicate that angiotensin II may not be contributing substantially to the induction of early growth response genes in the early stages of this process.
